Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.41T | 30.3x | 1.05 | SEK 1,557.50 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 101.25B | 23.1x | 0.23 | SEK 293.80 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.9% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 66.75B | 118.6x | 3.79 | SEK 346.40 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.1% Downside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 55.73B | 37.4x | -0.9 | SEK 211.10 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.9% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 42.34B | 58.2x | 0.27 | SEK 713.50 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.5% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 40.24B | 83x | 0.97 | SEK 266.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.6% Downside | Upgrade to Pro+ | |
Asker Healthcare AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 37.64B | 64.8x | SEK 101.72 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | ||
Alvotech DRC | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 23.90B | 38.9x | 0.38 | SEK 78.70 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 23.41B | 25.8x | 0.03 | SEK 263.80 | 12.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 21.13B | 62.9x | 0.33 | SEK 173.20 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.2% Upside | Upgrade to Pro+ | |
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 20.76B | -91.6x | -9.86 | SEK 69 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28% Downside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 19.48B | 132x | -2.7 | SEK 296.20 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 18.79B | 78.3x | -0.98 | SEK 49.28 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 18.54B | 40.9x | 0.36 | SEK 136.70 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.5% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 16.22B | 75.4x | 0.7 | SEK 32.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21% Upside | Upgrade to Pro+ | |
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 11.23B | 18.3x | 0.85 | SEK 136.80 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.15B | 35.2x | -1.21 | SEK 100.30 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 10.14B | 18.4x | 0.36 | SEK 68 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.61B | 22.3x | -1.41 | SEK 35.30 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.10B | 47.3x | 1.73 | SEK 265.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.9% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.62B | 101.6x | -6.82 | SEK 41.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 5.59B | 50.4x | -4.68 | SEK 177.40 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 5.33B | 58.2x | -1.12 | SEK 104 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 4.47B | 35.8x | 1.42 | SEK 249.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 4.46B | 18.3x | 0.82 | SEK 158.60 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.9% Upside | Upgrade to Pro+ | |
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 4.24B | 28.2x | 6.65 | SEK 177.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.4% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.12B | -12.7x | -0.18 | SEK 42 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.8% Upside | Upgrade to Pro+ | |
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.82B | -26x | 0.4 | SEK 9.92 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.70B | -3.6x | -0.12 | SEK 31.76 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.61B | -5.9x | 1.77 | SEK 11.12 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.42B | -53x | -3.14 | SEK 147.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.22B | -4.7x | 0.13 | SEK 33.45 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carasent AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.08B | -57.2x | 0.24 | SEK 27.25 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Humana | Stockholm | Healthcare | Healthcare Providers & Services | SEK 2.08B | 10.1x | 0.12 | SEK 41.70 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
Stille AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.04B | 39x | -2.63 | SEK 227 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.94B | -5.7x | -0.26 | SEK 5.30 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.82B | 6.8x | 0.03 | SEK 13.20 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.5% Downside | Upgrade to Pro+ | |
ADDvise Group AB A | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.78B | -9.9x | 0.18 | SEK 2.93 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.77B | -4.3x | -0.08 | SEK 24.90 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.4% Upside | Upgrade to Pro+ | |
Paxman | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.74B | 171.9x | -2.83 | SEK 75 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.1% Upside | Upgrade to Pro+ | |
Genovis AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.65B | 60.7x | 1.06 | SEK 25 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.4% Upside | Upgrade to Pro+ | |
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.63B | -6.2x | 2.61 | SEK 44.05 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sedana Medical | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.63B | -32.1x | 1.46 | SEK 16.52 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.2% Upside | Upgrade to Pro+ | |
OssDsign | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.58B | -29.9x | -0.48 | SEK 14.26 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.55B | -6.6x | 0.94 | SEK 11.26 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 1.38B | -12.4x | -1.35 | SEK 0.96 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C-Rad | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.11B | 43.7x | -0.84 | SEK 33 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.9% Upside | Upgrade to Pro+ | |
Hamlet Pharma AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 1.07B | -25.3x | -1.66 | SEK 6.09 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senzime | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.05B | -6.9x | -0.52 | SEK 6.71 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncopeptides | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.01B | -3.6x | 1.18 | SEK 4.47 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.8% Downside | Upgrade to Pro+ |